Combination and sequential therapy for osteoporosis

New England Journal of Medicine

Volumn 353, Issue 6, 2005, Pages 624-625

  Heaney, Robert P ^a   Recker, Robert R ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ALENDRONIC ACID; PARATHYROID HORMONE;

BONE MASS; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; HUMAN; MEDICAL PRACTICE; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; BONE DENSITY; BONE REMODELING; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; NOTE; POSTMENOPAUSE OSTEOPOROSIS;

ALENDRONATE; BONE DENSITY; BONE REMODELING; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE;

EID: 23444450743     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe058154     Document Type: Editorial

References (6)

1. Dowd R, Recker RR, Heaney RP. Study subjects and ordinary patients. Osteoporos Int 2000;11:533-6.
2. Recker RR, Lappe JM, Davies KM, Heaney RP. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res 2004;19:1628-33.
3. Black DM, Bilezikian JP, Ensrud KE, et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 2005;353:555-65.
4. Cosman F, Nieves J, Zion M, Woelfert L, Luckey M, Lindsay R. Daily and cyclic parathyroid hormone in women receiving alendronate. N Engl J Med 2005;353:566-75.
5. Heaney RP. Is the paradigm shifting? Bone 2003;33:457-65.
6. Uusi-Rasi K, Semanick LM, Zanchetta JR, et al. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 2005;36:948-58.